Alkem Laboratories Limited Overview
Pro stress-test →Alkem Laboratories is an Indian pharmaceutical company that develops, manufactures, and sells branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals across acute and chronic therapeutic areas including anti-infectives, pain management, cardiology, and diabetology, marketed in Indian and international markets. The company holds a 4.1% market share in the Indian domestic formulation market as of 9M FY25, making it the 5th largest pharmaceutical company in India.
Strategic Profile
Pro stress-test →Alkem maintains its #1 position in anti-infectives and has strong presence in gastrointestinal, pain management, vitamins, minerals, and nutrients segments while expanding in chronic therapies like neurology, cardiology, and diabetology. The company is positioned for sustained outperformance through accelerating margin expansion, product leadership in domestic therapies, and strategic R&D investments supporting biopharma and complex generic growth.
Competitive Landscape
Pro stress-test →Alkem competes with 68 other companies in the pharmaceutical sector, including Torrent Pharmaceuticals, Cipla, Mankind Pharma, and Marksans Pharma. As the 5th largest pharma company in India with 4.1% market share, Alkem faces intense competition from larger and smaller peers in both branded and generic segments.
Industry Context
Alkem Laboratories Limited operates in Pharmaceuticals & Biotechnology.
Key facts
Founded: 1973 · Headquarters: Mumbai, India · Employees: 22,833 · Revenue: $1.6B · Market cap: $7.59B